稳健医疗：控股股东表示对公司发展充满信心

Core Viewpoint - The controlling shareholder of Weijian Medical, Weijian Group Co., Ltd., has expressed confidence in the company's future development and has voluntarily extended the lock-up period for two consecutive years after the IPO lock-up expiration, which will end on September 16, 2025 [2] Summary by Relevant Sections - Shareholder Commitment - The controlling shareholder has committed to extending the lock-up period voluntarily for two years post-IPO [2] - The lock-up period is set to expire on September 16, 2025 [2] - Business Outlook - The controlling shareholder is optimistic about the development of the two main business segments: "medical" and "consumer" [2] - There are currently no plans for share reduction after the lock-up period expires [2] - Disclosure Compliance - If there are future plans for share reduction by the controlling shareholder, the company will ensure compliance with legal and regulatory requirements for timely and accurate information disclosure [2]